DENTSPLY SIRONA Inc (OQ:XRAY)

Business Focus: Medical Equipment, Supplies & Distribution

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution
 
See Regulatory Filings on SEC
Company Contact
Address: Suite 60W, 221 West Philadelphia Street
YORK PA 28277-3607
Tel: N/A
Website: https://www.dentsplysirona.com
IR: See website
<
Key People
Simon D. Campion
President, Chief Executive Officer, Director
Glenn G. Coleman
Chief Financial Officer, Executive Vice President
Lisa M. Yankie
Senior Vice President, Chief Human Resources Officer and Communications
Andreas G. Frank
Executive Vice President, Chief Business Officer
Erania Brackett
Senior Vice President, Chief Marketing Officer
Richard C. Rosenzweig
Senior Vice President - Corporate Development, General Counsel, Secretary
Richard M. Wagner
Chief Accounting Officer
Robert A. Johnson
Chief Supply Chain Officer
 
Business Overview
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. It develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of its value-added endodontic, restorative, and preventive consumable products and small equipment used in dental offices for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and dental professional directed aligner solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
Financial Overview
For the three months ended 31 March 2024, DENTSPLY SIRONA Inc revenues decreased 3% to $953M. Net income totaled $18M vs. loss of $19M. Revenues reflect Europe segment decrease of 5% to $376M, Rest of World segment decrease of 4% to $221M. Net Income reflects Restructuring and other costs decrease of 98% to $1M (expense), Other expense (income), net - Balancing increase from $3M (expense) to $16M (income).
Employees: 15,000 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $7,590M as of Mar 31, 2024
Annual revenue (TTM): $3,940M as of Mar 31, 2024
EBITDA (TTM): $628.00M as of Mar 31, 2024
Net annual income (TTM): -$95.00M as of Mar 31, 2024
Free cash flow (TTM): $161.00M as of Mar 31, 2024
Net Debt Last Fiscal Year: $1,799M as of Mar 31, 2024
Shares outstanding: 207,630,556 as of Apr 19, 2024
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.